
Clinically suspected myocarditis in COVID‐19 patients: Case series and review of the literature
Author(s) -
Amin Ahmad,
Eftekhar Seyed Parsa,
Ziaie Naghmeh,
Roudbari Soudeh,
Salehi Pegah,
Jalali Farzad,
Jafaripour Iraj,
Ghaffari Sanaz,
Mohseni Salehi Maryam,
Ebadi Reza
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5236
Subject(s) - medicine , covid-19 , prohormone , ejection fraction , myocarditis , cardiology , natriuretic peptide , brain natriuretic peptide , viral myocarditis , disease , pathology , heart failure , infectious disease (medical specialty) , hormone , outbreak
This Study describes eleven patients positive for severe acute respiratory syndrome coronavirus 2. In our cases, females and younger patients developed more severe disease. In contrast, improvement in left ventricular ejection fraction and N‐terminal prohormone brain natriuretic peptide within the first week of treatment contributed to promising outcomes.